Emergent to make Calgary-based Providence Therapeutics' potential COVID-19 vaccine
Emergent BioSolutions Inc. signed a five-year agreement with Calgary-based biotechnology company Providence Therapeutics to develop and manufacture its COVID-19 vaccine candidate for about $90 million.
More... From http://start.westnet.ca News News Provided By WestNet Wireless Internet |
All times are GMT. The time now is 08:58 AM. |